Provided by Tiger Fintech (Singapore) Pte. Ltd.

Corcept Therapeutics

62.24
-2.3600-3.65%
Post-market: 63.501.26+2.02%19:59 EDT
Volume:1.58M
Turnover:99.30M
Market Cap:6.57B
PE:50.60
High:65.40
Open:64.60
Low:61.94
Close:64.60
Loading ...

Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol

Zacks
·
03 Feb

Corcept (CORT) Soars 13.6%: Is Further Upside Left in the Stock?

Zacks
·
31 Jan

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era

Zacks
·
31 Jan

Should Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) Be on Your Investing Radar?

Zacks
·
31 Jan

Corcept Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
31 Jan

Top Stock Reports for American Express, Lockheed Martin & Constellation Energy

Zacks
·
30 Jan

All You Need to Know About Corcept (CORT) Rating Upgrade to Strong Buy

Zacks
·
30 Jan

Buy These 5 Stocks With Recent Price Strength Amid a Volatile January

Zacks
·
29 Jan

Corcept Therapeutics Incorporated (CORT) Hit a 52 Week High, Can the Run Continue?

Zacks
·
24 Jan

Medical Stock Soars To Highs As Cortisol Screening Grows

Blockhead
·
23 Jan

Here’s Why Analysts Are Bullish on Corcept Therapeutics Incorporated (CORT)

Insider Monkey
·
21 Jan

Corcept Therapeutics Incorporated (CORT): Why Should You Buy This Growth Stock For The Next 5 Years?

Insider Monkey
·
19 Jan

Corcept Therapeutics Incorporated (CORT) Surged on Strong Results and Increased Guidance

Insider Monkey
·
07 Jan

Corcept Submits Application for Another Cushing's Syndrome Drug

Zacks
·
01 Jan

Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
31 Dec 2024

Corcept Therapeutics Submits New Drug Application for Cushing's Sydrome Treatment

Dow Jones
·
31 Dec 2024

Corcept Therapeutics Files New Drug Application for Relacorilant

MT Newswires Live
·
31 Dec 2024

BRIEF-Corcept Submits New Drug Application For Relacorilant As A Treatment For Patients With Hypercortisolism

Reuters
·
31 Dec 2024

Corcept Therapeutics submits relacorilant new drug application to FDA

TIPRANKS
·
31 Dec 2024

Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism

THOMSON REUTERS
·
31 Dec 2024